Sinocare Inc. (SHE:300298)

Market Cap	8.11B -32.0%
Revenue (ttm)	4.86B +8.6%
Net Income	118.22M -62.8%
EPS	0.22 -62.3%
Shares Out	546.53M
PE Ratio	68.67
Forward PE	19.99
Dividend	0.22 (1.48%)
Ex-Dividend Date	Jun 13, 2025

Volume	3,429,500
Open	15.57
Previous Close	15.10
Day's Range	14.84 - 15.57
52-Week Range	14.84 - 23.96
Beta	-0.08
Analysts	Strong Buy
Price Target	22.84 (+53.91%)
Earnings Date	Aug 28, 2026

About Sinocare

Sinocare Inc. engages in the development, manufacture, and marketing of rapid diagnosis testing products primarily in the People’s Republic of China. It offers blood glucose and pressure monitors; point of care testing products; digital management tool solutions; non-invasive screening products; and PTS and Trividia products. The company provides its products for the patients with chronic diseases and diabetes, as well as for healthcare professionals. It also exports its products. The company was founded in 2002 and is based in Changsha, the Pe...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2002
• Employees: 5,010
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300298

Financial Performance

In 2025, Sinocare's revenue was 4.66 billion, an increase of 4.87% compared to the previous year's 4.44 billion. Earnings were 92.65 million, a decrease of -71.61%.